Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate

• Hoofdauteurs: Charmi Patel (Auteur), Bruno Emond (Auteur), Marie-Hélène Lafeuille (Auteur), Aurélie Côté-Sergent (Auteur), Patrick Lefebvre (Auteur), Neeta Tandon (Auteur), Antoine C. El Khoury (Auteur)
• Formaat: Boek
• Gepubliceerd in: Adis, Springer Healthcare, 2019-11-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Abstract Purpose Reducing the dosing frequency of antipsychotics (APs) with long-acting injectables (LAIs) such as once-monthly paliperidone palmitate (PP1M) can improve adherence and clinical outcomes for schizophrenia patients. This US study compared physical and psychiatric comorbidity-related ou...